LabGenomics Co., Ltd. (KOSDAQ:084650)
South Korea · Delayed Price · Currency is KRW 836.00
+13.00 (1.58%)
Aug 11, 2026, 2:10 PM KST
LabGenomics Market Cap
LabGenomics has a market cap or net worth of 61.1 billion as of August 10, 2026. Its market cap has decreased by -66.27% in one year.
Market Cap
61.10B
Enterprise Value
68.70B
Revenue
84.19B
Ranking
n/a
PE Ratio
n/a
Stock Price
836.00
ChartMarket Cap Chart
Since December 16, 2014, LabGenomics's market cap has increased from 56.52B to 61.10B, an increase of 8.10%. That is a compound annual growth rate of 0.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 61.10B | -54.56% |
| Dec 30, 2025 | 134.45B | -27.27% |
| Dec 30, 2024 | 184.86B | -35.41% |
| Dec 28, 2023 | 286.20B | 33.64% |
| Dec 29, 2022 | 214.15B | -23.76% |
| Dec 30, 2021 | 280.90B | 31.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| T&R Biofab | 123.21B |
| Osang Healthcare Co.,Ltd | 98.79B |
| Ray Co., Ltd. | 89.30B |
| Access Bio | 82.48B |
| P&S Robotics | 78.44B |
| Sugentech | 70.33B |
| DRTECH | 68.62B |
| Humasis | 55.56B |